

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.88787539 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.88787539 |
| 3 | exogenous drug catabolic process (GO:0042738) | 6.79812439 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.57361360 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.57361360 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.40946272 |
| 7 | drug catabolic process (GO:0042737) | 6.35015809 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.07502295 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.07502295 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.07502295 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 5.73971158 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.72039610 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 5.71677810 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.71184389 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.69067228 |
| 16 | regulation of plasminogen activation (GO:0010755) | 5.65931991 |
| 17 | complement activation, alternative pathway (GO:0006957) | 5.54842074 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.52086787 |
| 19 | regulation of protein activation cascade (GO:2000257) | 5.36216696 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.22870104 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.22015026 |
| 22 | urea metabolic process (GO:0019627) | 5.19677529 |
| 23 | urea cycle (GO:0000050) | 5.19677529 |
| 24 | regulation of complement activation (GO:0030449) | 5.08455600 |
| 25 | omega-hydroxylase P450 pathway (GO:0097267) | 5.04601362 |
| 26 | protein carboxylation (GO:0018214) | 5.03159441 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.03159441 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.02492486 |
| 29 | negative regulation of protein activation cascade (GO:2000258) | 4.91865506 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 4.91703014 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88252660 |
| 32 | regulation of fibrinolysis (GO:0051917) | 4.85885281 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.84627558 |
| 34 | cysteine metabolic process (GO:0006534) | 4.82521063 |
| 35 | tyrosine metabolic process (GO:0006570) | 4.80902431 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.78781467 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.76379270 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.75526050 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.74585449 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.67820542 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.67820542 |
| 42 | bile acid metabolic process (GO:0008206) | 4.67319223 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.61580979 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.55959987 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.46910596 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.44718651 |
| 47 | cellular biogenic amine catabolic process (GO:0042402) | 4.42010836 |
| 48 | amine catabolic process (GO:0009310) | 4.42010836 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.34828875 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.34828875 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.34828875 |
| 52 | lysine metabolic process (GO:0006553) | 4.34680073 |
| 53 | lysine catabolic process (GO:0006554) | 4.34680073 |
| 54 | reverse cholesterol transport (GO:0043691) | 4.34625654 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.34124948 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.34124948 |
| 57 | plasma lipoprotein particle organization (GO:0071827) | 4.33952838 |
| 58 | drug metabolic process (GO:0017144) | 4.30642842 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.30346775 |
| 60 | coenzyme catabolic process (GO:0009109) | 4.29040650 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 4.28678996 |
| 62 | acute-phase response (GO:0006953) | 4.27576705 |
| 63 | regulation of humoral immune response (GO:0002920) | 4.26156915 |
| 64 | protein-lipid complex assembly (GO:0065005) | 4.24195763 |
| 65 | positive regulation of blood coagulation (GO:0030194) | 4.23626354 |
| 66 | positive regulation of hemostasis (GO:1900048) | 4.23626354 |
| 67 | negative regulation of complement activation (GO:0045916) | 4.19266780 |
| 68 | phospholipid efflux (GO:0033700) | 4.18747391 |
| 69 | regulation of apoptotic cell clearance (GO:2000425) | 4.18598850 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.15454521 |
| 71 | negative regulation of wound healing (GO:0061045) | 4.12364967 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 4.11230682 |
| 73 | oxidative demethylation (GO:0070989) | 4.10754793 |
| 74 | cellular glucuronidation (GO:0052695) | 4.06795335 |
| 75 | protein-lipid complex subunit organization (GO:0071825) | 4.06362026 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 4.05967950 |
| 77 | bile acid and bile salt transport (GO:0015721) | 4.05622696 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05563712 |
| 79 | plasma lipoprotein particle clearance (GO:0034381) | 4.04386784 |
| 80 | cellular ketone body metabolic process (GO:0046950) | 4.01274006 |
| 81 | ethanol metabolic process (GO:0006067) | 3.95847823 |
| 82 | ethanol oxidation (GO:0006069) | 3.93510692 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 3.91971684 |
| 84 | negative regulation of sterol transport (GO:0032372) | 3.91971684 |
| 85 | glycine metabolic process (GO:0006544) | 3.90735702 |
| 86 | fibrinolysis (GO:0042730) | 3.90408460 |
| 87 | positive regulation of coagulation (GO:0050820) | 3.85319186 |
| 88 | short-chain fatty acid metabolic process (GO:0046459) | 3.84851448 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 3.81893341 |
| 90 | phenylpropanoid metabolic process (GO:0009698) | 3.81518017 |
| 91 | cholesterol efflux (GO:0033344) | 3.79927254 |
| 92 | glutamate metabolic process (GO:0006536) | 3.79312123 |
| 93 | complement activation (GO:0006956) | 3.77444873 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76886869 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.76405700 |
| 96 | arginine metabolic process (GO:0006525) | 3.74278267 |
| 97 | protein activation cascade (GO:0072376) | 3.72956673 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.72755739 |
| 99 | ketone body metabolic process (GO:1902224) | 3.70582090 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.70512394 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.67059591 |
| 102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.66830653 |
| 103 | cytolysis (GO:0019835) | 3.63824206 |
| 104 | organic acid catabolic process (GO:0016054) | 3.63055831 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.63055831 |
| 106 | flavonoid metabolic process (GO:0009812) | 3.62946439 |
| 107 | cofactor catabolic process (GO:0051187) | 3.62389936 |
| 108 | phospholipid homeostasis (GO:0055091) | 3.60297838 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60202347 |
| 110 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.58436333 |
| 111 | lipoprotein metabolic process (GO:0042157) | 3.57696571 |
| 112 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.57664804 |
| 113 | fatty acid beta-oxidation (GO:0006635) | 3.56948514 |
| 114 | NAD biosynthetic process (GO:0009435) | 3.55951510 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 3.55843243 |
| 116 | glucuronate metabolic process (GO:0019585) | 3.55558227 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.55558227 |
| 118 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.52545958 |
| 119 | carnitine metabolic process (GO:0009437) | 3.52221419 |
| 120 | aldehyde catabolic process (GO:0046185) | 3.51928040 |
| 121 | response to mercury ion (GO:0046689) | 3.51805298 |
| 122 | fatty acid oxidation (GO:0019395) | 3.51110617 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 3.50520181 |
| 124 | positive regulation of lipid catabolic process (GO:0050996) | 3.49774848 |
| 125 | drug transmembrane transport (GO:0006855) | 3.49194035 |
| 126 | serine family amino acid biosynthetic process (GO:0009070) | 3.48842437 |
| 127 | cholesterol homeostasis (GO:0042632) | 3.47572387 |
| 128 | lipid oxidation (GO:0034440) | 3.47470443 |
| 129 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.47288474 |
| 130 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.47288474 |
| 131 | intestinal absorption (GO:0050892) | 3.46334035 |
| 132 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44586452 |
| 133 | proline metabolic process (GO:0006560) | 3.44193509 |
| 134 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.44003444 |
| 135 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.41679621 |
| 136 | sterol transport (GO:0015918) | 3.40704301 |
| 137 | cholesterol transport (GO:0030301) | 3.40704301 |
| 138 | sterol homeostasis (GO:0055092) | 3.40321823 |
| 139 | S-adenosylmethionine metabolic process (GO:0046500) | 3.38840135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.84814832 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.94187884 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.72785143 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09638909 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.31911227 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.03128676 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.80500189 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86924839 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.60803625 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11512527 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9010061 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97671194 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.80434063 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73119763 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66814617 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65919476 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65688218 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63983393 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57649988 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55635477 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53271428 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52400704 |
| 23 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42240823 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42226105 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37757220 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36300810 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31230342 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.31218458 |
| 29 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26381188 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25346730 |
| 31 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16320234 |
| 32 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11021027 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10288000 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09432775 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08441699 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02713812 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96740563 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95099760 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95036464 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94617065 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94594592 |
| 42 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.92572972 |
| 43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91971832 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90924537 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88658892 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86568223 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85913819 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85913819 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.85456363 |
| 50 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82704505 |
| 51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.82402444 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82371154 |
| 53 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82293713 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.82125842 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82062091 |
| 56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80357562 |
| 57 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.80303931 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79975383 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79577805 |
| 60 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79528644 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78969527 |
| 62 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78625447 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77801661 |
| 64 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.76186941 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75252160 |
| 66 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.73439124 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72623823 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.69495812 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69319872 |
| 70 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.69202024 |
| 71 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.68608336 |
| 72 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.68316835 |
| 73 | * ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68034130 |
| 74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.67771763 |
| 75 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67531443 |
| 76 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.67122048 |
| 77 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.66728462 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.65997691 |
| 79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64795423 |
| 80 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64577256 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64051922 |
| 82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63469993 |
| 83 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.62538586 |
| 84 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62531033 |
| 85 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.61719375 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60948488 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.60636203 |
| 88 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59867945 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59851241 |
| 90 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.59540415 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.59214460 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.58838335 |
| 93 | ERA_21632823_ChIP-Seq_H3396_Human | 0.58352713 |
| 94 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.57978581 |
| 95 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57952753 |
| 96 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57825133 |
| 97 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.57558502 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.57296469 |
| 99 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57063788 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.56667915 |
| 101 | TP53_16413492_ChIP-PET_HCT116_Human | 0.56003867 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55664433 |
| 103 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.55346458 |
| 104 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55163522 |
| 105 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.54920263 |
| 106 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.54742877 |
| 107 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.54553933 |
| 108 | * P68_20966046_ChIP-Seq_HELA_Human | 0.53526797 |
| 109 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53508685 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.53288406 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53286774 |
| 112 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.53228530 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.52272624 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.52193666 |
| 115 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.51980619 |
| 116 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51936661 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51091473 |
| 118 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.50093171 |
| 119 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.49908264 |
| 120 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.49290625 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.49100668 |
| 122 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.48995568 |
| 123 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48845752 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48329077 |
| 125 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.48276143 |
| 126 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.48051651 |
| 127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.46162380 |
| 128 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45985091 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44461880 |
| 130 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.44321783 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44084123 |
| 132 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.43719468 |
| 133 | CJUN_26792858_Chip-Seq_BT549_Human | 0.43254907 |
| 134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.42810174 |
| 135 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.42664299 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.42397353 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.42223271 |
| 138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.41718762 |
| 139 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.41196399 |
| 140 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.40762257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.53372194 |
| 2 | MP0005360_urolithiasis | 6.78601978 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.99087331 |
| 4 | MP0005365_abnormal_bile_salt | 5.70605739 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.78270600 |
| 6 | MP0003252_abnormal_bile_duct | 4.32481934 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.52251002 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.36073640 |
| 9 | MP0005083_abnormal_biliary_tract | 3.10206547 |
| 10 | MP0009840_abnormal_foam_cell | 2.87482534 |
| 11 | MP0003195_calcinosis | 2.71994584 |
| 12 | MP0005332_abnormal_amino_acid | 2.68936781 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.29427550 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.22138127 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.21785216 |
| 16 | MP0000609_abnormal_liver_physiology | 2.10434156 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.02458321 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01567535 |
| 19 | MP0002254_reproductive_system_inflammat | 1.97087663 |
| 20 | MP0003011_delayed_dark_adaptation | 1.86276283 |
| 21 | MP0005670_abnormal_white_adipose | 1.85629553 |
| 22 | MP0003122_maternal_imprinting | 1.75095359 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.74302022 |
| 24 | MP0001764_abnormal_homeostasis | 1.63929485 |
| 25 | MP0009697_abnormal_copulation | 1.56032178 |
| 26 | MP0003868_abnormal_feces_composition | 1.53776339 |
| 27 | MP0004381_abnormal_hair_follicle | 1.40518269 |
| 28 | MP0003186_abnormal_redox_activity | 1.39019920 |
| 29 | MP0009764_decreased_sensitivity_to | 1.37739322 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34465609 |
| 31 | MP0005451_abnormal_body_composition | 1.31005037 |
| 32 | MP0005647_abnormal_sex_gland | 1.30083199 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.22692022 |
| 34 | MP0002089_abnormal_postnatal_growth/wei | 1.15547285 |
| 35 | * MP0000598_abnormal_liver_morphology | 1.12091245 |
| 36 | MP0009763_increased_sensitivity_to | 1.09652607 |
| 37 | MP0005408_hypopigmentation | 1.09098411 |
| 38 | MP0001915_intracranial_hemorrhage | 1.04093895 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.03344022 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 0.95210713 |
| 41 | MP0010368_abnormal_lymphatic_system | 0.94983361 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 0.93793424 |
| 43 | MP0008469_abnormal_protein_level | 0.92388818 |
| 44 | MP0003879_abnormal_hair_cell | 0.87445399 |
| 45 | MP0000604_amyloidosis | 0.87033322 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 0.85708322 |
| 47 | MP0002971_abnormal_brown_adipose | 0.85434344 |
| 48 | MP0003724_increased_susceptibility_to | 0.84454015 |
| 49 | MP0002928_abnormal_bile_duct | 0.82427912 |
| 50 | MP0005330_cardiomyopathy | 0.80713768 |
| 51 | MP0009642_abnormal_blood_homeostasis | 0.79604449 |
| 52 | MP0002060_abnormal_skin_morphology | 0.78526228 |
| 53 | MP0005334_abnormal_fat_pad | 0.77890849 |
| 54 | MP0009765_abnormal_xenobiotic_induced | 0.75599713 |
| 55 | MP0003646_muscle_fatigue | 0.75406864 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.74717667 |
| 57 | MP0003436_decreased_susceptibility_to | 0.74699934 |
| 58 | MP0002796_impaired_skin_barrier | 0.74680093 |
| 59 | MP0002876_abnormal_thyroid_physiology | 0.74557274 |
| 60 | MP0005376_homeostasis/metabolism_phenot | 0.74554404 |
| 61 | MP0001661_extended_life_span | 0.73884904 |
| 62 | MP0005248_abnormal_Harderian_gland | 0.73392675 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 0.68976180 |
| 64 | MP0004130_abnormal_muscle_cell | 0.67730694 |
| 65 | MP0009384_cardiac_valve_regurgitation | 0.66732105 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 0.65893569 |
| 67 | MP0005377_hearing/vestibular/ear_phenot | 0.64160906 |
| 68 | MP0003878_abnormal_ear_physiology | 0.64160906 |
| 69 | MP0003690_abnormal_glial_cell | 0.63916398 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.63009174 |
| 71 | MP0002282_abnormal_trachea_morphology | 0.61119310 |
| 72 | MP0005666_abnormal_adipose_tissue | 0.60993969 |
| 73 | MP0003172_abnormal_lysosome_physiology | 0.60471171 |
| 74 | MP0001853_heart_inflammation | 0.59025400 |
| 75 | MP0008438_abnormal_cutaneous_collagen | 0.57499410 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.56216844 |
| 77 | MP0005409_darkened_coat_color | 0.56072127 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.55485550 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.54962388 |
| 80 | MP0005395_other_phenotype | 0.54777937 |
| 81 | MP0003950_abnormal_plasma_membrane | 0.54401798 |
| 82 | MP0002269_muscular_atrophy | 0.54195183 |
| 83 | MP0000579_abnormal_nail_morphology | 0.53960449 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.53272176 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.51032338 |
| 86 | MP0003718_maternal_effect | 0.50388181 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.49637709 |
| 88 | MP0001243_abnormal_dermal_layer | 0.49380577 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.49301900 |
| 90 | MP0005164_abnormal_response_to | 0.48486351 |
| 91 | MP0004272_abnormal_basement_membrane | 0.48483063 |
| 92 | MP0009115_abnormal_fat_cell | 0.48310734 |
| 93 | MP0001756_abnormal_urination | 0.48235771 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.48042110 |
| 95 | MP0004043_abnormal_pH_regulation | 0.47302791 |
| 96 | MP0005535_abnormal_body_temperature | 0.46917193 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 0.46606129 |
| 98 | MP0000566_synostosis | 0.45616485 |
| 99 | MP0001324_abnormal_eye_pigmentation | 0.44876419 |
| 100 | MP0002909_abnormal_adrenal_gland | 0.44656426 |
| 101 | MP0001881_abnormal_mammary_gland | 0.44466286 |
| 102 | MP0003638_abnormal_response/metabolism_ | 0.43760100 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.43752748 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 0.43218956 |
| 105 | MP0006082_CNS_inflammation | 0.43098119 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.43068969 |
| 107 | MP0008872_abnormal_physiological_respon | 0.42138875 |
| 108 | MP0004883_abnormal_blood_vessel | 0.41483107 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.41414080 |
| 110 | MP0002168_other_aberrant_phenotype | 0.40966113 |
| 111 | MP0000249_abnormal_blood_vessel | 0.40568252 |
| 112 | MP0003123_paternal_imprinting | 0.40491428 |
| 113 | MP0003953_abnormal_hormone_level | 0.40327193 |
| 114 | MP0000371_diluted_coat_color | 0.40114241 |
| 115 | MP0002132_abnormal_respiratory_system | 0.39520080 |
| 116 | MP0005266_abnormal_metabolism | 0.39227501 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.37782247 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 0.37244639 |
| 119 | MP0010630_abnormal_cardiac_muscle | 0.37221132 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.36747675 |
| 121 | MP0000467_abnormal_esophagus_morphology | 0.36566941 |
| 122 | MP0005448_abnormal_energy_balance | 0.35951594 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.35915806 |
| 124 | MP0005501_abnormal_skin_physiology | 0.35456042 |
| 125 | MP0005275_abnormal_skin_tensile | 0.35429643 |
| 126 | MP0005410_abnormal_fertilization | 0.34200175 |
| 127 | MP0000751_myopathy | 0.33703784 |
| 128 | MP0008775_abnormal_heart_ventricle | 0.33534192 |
| 129 | MP0005187_abnormal_penis_morphology | 0.32582732 |
| 130 | MP0006138_congestive_heart_failure | 0.32079759 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.31486845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.95910246 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.64226650 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.56789521 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.33221945 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.27181607 |
| 6 | Xanthomatosis (HP:0000991) | 6.03350628 |
| 7 | Complement deficiency (HP:0004431) | 5.58271944 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.49666071 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.35873038 |
| 10 | Joint hemorrhage (HP:0005261) | 4.96799878 |
| 11 | Hyperammonemia (HP:0001987) | 4.54296377 |
| 12 | Hyperglycinuria (HP:0003108) | 4.54013918 |
| 13 | Hyperglycinemia (HP:0002154) | 4.45026516 |
| 14 | Epidermoid cyst (HP:0200040) | 4.44258986 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.36183384 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.29589890 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.28953399 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.23525184 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.23525184 |
| 20 | Abnormality of complement system (HP:0005339) | 4.15871894 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13094622 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10782770 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.09232092 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08701470 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 4.07942553 |
| 26 | Ketosis (HP:0001946) | 3.98604380 |
| 27 | Fat malabsorption (HP:0002630) | 3.84392703 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82125656 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.81684730 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.73756823 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.61359230 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.47394049 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45975978 |
| 34 | Myocardial infarction (HP:0001658) | 3.42814022 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.27198659 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23299895 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.10695122 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.07145586 |
| 39 | Steatorrhea (HP:0002570) | 3.00386955 |
| 40 | Hepatocellular carcinoma (HP:0001402) | 2.90955850 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.89773924 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.84303646 |
| 43 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82712625 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 2.82712625 |
| 45 | Ketoacidosis (HP:0001993) | 2.80006054 |
| 46 | Vascular calcification (HP:0004934) | 2.79419060 |
| 47 | Glomerulonephritis (HP:0000099) | 2.74262919 |
| 48 | Retinal atrophy (HP:0001105) | 2.71996780 |
| 49 | Spontaneous abortion (HP:0005268) | 2.66069960 |
| 50 | Metabolic acidosis (HP:0001942) | 2.65516227 |
| 51 | Skin nodule (HP:0200036) | 2.64692150 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 2.63853094 |
| 53 | Hydroxyprolinuria (HP:0003080) | 2.63853094 |
| 54 | Purpura (HP:0000979) | 2.60326751 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.59985632 |
| 56 | Lethargy (HP:0001254) | 2.57936321 |
| 57 | Amyloidosis (HP:0011034) | 2.55341422 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50930207 |
| 59 | Arthropathy (HP:0003040) | 2.50428462 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.49570294 |
| 61 | Gingival bleeding (HP:0000225) | 2.48902519 |
| 62 | Esophageal varix (HP:0002040) | 2.46246711 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.45276946 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.43598058 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.42219185 |
| 66 | Cholecystitis (HP:0001082) | 2.42219185 |
| 67 | Enlarged kidneys (HP:0000105) | 2.39129425 |
| 68 | Increased serum pyruvate (HP:0003542) | 2.35123960 |
| 69 | Mitral stenosis (HP:0001718) | 2.32950492 |
| 70 | Spastic diplegia (HP:0001264) | 2.30972246 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.25688590 |
| 72 | Menorrhagia (HP:0000132) | 2.22905952 |
| 73 | Renal cortical cysts (HP:0000803) | 2.22182018 |
| 74 | Pancreatitis (HP:0001733) | 2.20636740 |
| 75 | Osteomalacia (HP:0002749) | 2.18711241 |
| 76 | Abnormal tarsal ossification (HP:0008369) | 2.18625607 |
| 77 | Neonatal onset (HP:0003623) | 2.09050180 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.08726046 |
| 79 | Abnormality of glycolysis (HP:0004366) | 2.07837528 |
| 80 | Rickets (HP:0002748) | 2.07172563 |
| 81 | Opisthotonus (HP:0002179) | 2.06647030 |
| 82 | Poikilocytosis (HP:0004447) | 2.06208236 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.05645522 |
| 84 | Nephritis (HP:0000123) | 2.03928047 |
| 85 | Cerebral edema (HP:0002181) | 2.03485632 |
| 86 | Irritability (HP:0000737) | 2.00797623 |
| 87 | Vomiting (HP:0002013) | 2.00436764 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.00329687 |
| 89 | Hemorrhage of the eye (HP:0011885) | 1.99983202 |
| 90 | Acanthocytosis (HP:0001927) | 1.98567790 |
| 91 | Abnormality of carpal bone ossification (HP:0006257) | 1.98018749 |
| 92 | Abnormality of the Achilles tendon (HP:0005109) | 1.97161527 |
| 93 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93729738 |
| 94 | Malnutrition (HP:0004395) | 1.92930894 |
| 95 | Hypertriglyceridemia (HP:0002155) | 1.92856700 |
| 96 | Thrombophlebitis (HP:0004418) | 1.92598094 |
| 97 | Cholelithiasis (HP:0001081) | 1.92476310 |
| 98 | Gout (HP:0001997) | 1.91888048 |
| 99 | Brushfield spots (HP:0001088) | 1.91290113 |
| 100 | Hypophosphatemic rickets (HP:0004912) | 1.90023743 |
| 101 | Late onset (HP:0003584) | 1.89710000 |
| 102 | Bifid scrotum (HP:0000048) | 1.89534777 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 1.89337702 |
| 104 | Pulmonary embolism (HP:0002204) | 1.89254994 |
| 105 | Elevated hepatic transaminases (HP:0002910) | 1.89137299 |
| 106 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.88666956 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85684109 |
| 108 | Glycosuria (HP:0003076) | 1.85434701 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 1.85434701 |
| 110 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84457642 |
| 111 | Fair hair (HP:0002286) | 1.81896903 |
| 112 | Facial shape deformation (HP:0011334) | 1.80055885 |
| 113 | Potter facies (HP:0002009) | 1.80055885 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.77351936 |
| 115 | Bile duct proliferation (HP:0001408) | 1.77016863 |
| 116 | Abnormal biliary tract physiology (HP:0012439) | 1.77016863 |
| 117 | Nausea (HP:0002018) | 1.76648385 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 1.75585004 |
| 119 | Alkalosis (HP:0001948) | 1.73626051 |
| 120 | Hyperphosphaturia (HP:0003109) | 1.71581310 |
| 121 | Proximal tubulopathy (HP:0000114) | 1.69715913 |
| 122 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68704403 |
| 123 | Abnormality of the nasal septum (HP:0000419) | 1.57655018 |
| 124 | Broad alveolar ridges (HP:0000187) | 1.52767264 |
| 125 | Joint swelling (HP:0001386) | 1.51017256 |
| 126 | Abnormal urine phosphate concentration (HP:0012599) | 1.49352492 |
| 127 | Vaginal fistula (HP:0004320) | 1.48710712 |
| 128 | Neoplasm of the liver (HP:0002896) | 1.47144452 |
| 129 | Glomerulosclerosis (HP:0000096) | 1.46488413 |
| 130 | Gangrene (HP:0100758) | 1.46484240 |
| 131 | Increased serum ferritin (HP:0003281) | 1.46257210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.41090995 |
| 2 | SIK1 | 3.98017959 |
| 3 | WNK4 | 3.80399205 |
| 4 | ERN1 | 3.61638408 |
| 5 | FGFR4 | 3.59442276 |
| 6 | MST1R | 3.08440370 |
| 7 | ICK | 2.94179853 |
| 8 | INSRR | 2.73986059 |
| 9 | TAOK3 | 2.66209620 |
| 10 | STK38L | 2.46983673 |
| 11 | ERBB4 | 2.45762234 |
| 12 | IRAK3 | 2.38713105 |
| 13 | SIK2 | 2.16098056 |
| 14 | PDK2 | 2.06331777 |
| 15 | PIK3CG | 2.02403327 |
| 16 | TGFBR2 | 1.98478500 |
| 17 | MAP3K14 | 1.91509819 |
| 18 | TIE1 | 1.74124249 |
| 19 | OBSCN | 1.62415692 |
| 20 | ADRBK2 | 1.61818958 |
| 21 | TYK2 | 1.60739373 |
| 22 | LATS1 | 1.58811145 |
| 23 | NUAK1 | 1.54108767 |
| 24 | MAP3K7 | 1.48174001 |
| 25 | MAPK11 | 1.47900355 |
| 26 | KDR | 1.46608774 |
| 27 | FGFR1 | 1.44260158 |
| 28 | NTRK3 | 1.36560673 |
| 29 | STK39 | 1.35359288 |
| 30 | FLT3 | 1.30852650 |
| 31 | CAMK1D | 1.28984154 |
| 32 | ZAK | 1.28842313 |
| 33 | PIK3CA | 1.27030327 |
| 34 | MET | 1.26647086 |
| 35 | PDPK1 | 1.26431011 |
| 36 | TBK1 | 1.25031295 |
| 37 | MAPKAPK3 | 1.23768695 |
| 38 | EPHA2 | 1.23393221 |
| 39 | NEK1 | 1.20393726 |
| 40 | NEK9 | 1.19602041 |
| 41 | PRKAA2 | 1.17729899 |
| 42 | EPHA3 | 1.17361377 |
| 43 | CDK12 | 1.14096744 |
| 44 | MAP2K3 | 1.13513088 |
| 45 | IKBKE | 1.13287326 |
| 46 | PTK6 | 1.07994810 |
| 47 | GRK1 | 1.04064561 |
| 48 | WNK3 | 1.03612363 |
| 49 | MAP3K3 | 1.03344180 |
| 50 | EIF2AK1 | 1.02656201 |
| 51 | MAP2K4 | 1.01284037 |
| 52 | MAPK15 | 1.00149709 |
| 53 | CDK6 | 0.99260108 |
| 54 | ABL2 | 0.98932342 |
| 55 | ERBB2 | 0.97303316 |
| 56 | JAK1 | 0.95147591 |
| 57 | BLK | 0.92395494 |
| 58 | MYLK | 0.91942502 |
| 59 | MAPK7 | 0.91079311 |
| 60 | MAP3K2 | 0.89479451 |
| 61 | JAK2 | 0.88668030 |
| 62 | MAP4K2 | 0.88010223 |
| 63 | PKN2 | 0.87766563 |
| 64 | TYRO3 | 0.85295743 |
| 65 | RET | 0.85017721 |
| 66 | PBK | 0.84327008 |
| 67 | KIT | 0.84167657 |
| 68 | WNK1 | 0.83513631 |
| 69 | EIF2AK2 | 0.81674205 |
| 70 | DYRK1B | 0.80247730 |
| 71 | TRIB3 | 0.79775464 |
| 72 | GSK3A | 0.79658278 |
| 73 | MUSK | 0.79226872 |
| 74 | CSK | 0.78557091 |
| 75 | PKN1 | 0.77597351 |
| 76 | SGK223 | 0.77044297 |
| 77 | SGK494 | 0.77044297 |
| 78 | STK16 | 0.76349381 |
| 79 | MAPK4 | 0.75739454 |
| 80 | PDK1 | 0.75518724 |
| 81 | AKT3 | 0.74505007 |
| 82 | IKBKB | 0.71218468 |
| 83 | PDGFRA | 0.70604680 |
| 84 | PINK1 | 0.69561635 |
| 85 | BMX | 0.68279739 |
| 86 | MAPK12 | 0.68034103 |
| 87 | MARK3 | 0.67062977 |
| 88 | BCR | 0.66702279 |
| 89 | EPHB2 | 0.65480213 |
| 90 | BRD4 | 0.65217433 |
| 91 | FGFR2 | 0.64946529 |
| 92 | RIPK1 | 0.63861676 |
| 93 | EEF2K | 0.62928954 |
| 94 | FGFR3 | 0.62842145 |
| 95 | TEC | 0.61440434 |
| 96 | PRKACA | 0.60929713 |
| 97 | CSNK1D | 0.59906197 |
| 98 | CHUK | 0.59645237 |
| 99 | FRK | 0.59243302 |
| 100 | PHKG2 | 0.58316630 |
| 101 | PHKG1 | 0.58316630 |
| 102 | PRKCG | 0.57608432 |
| 103 | LMTK2 | 0.57126306 |
| 104 | IRAK1 | 0.56594797 |
| 105 | SGK1 | 0.55489496 |
| 106 | CSNK1E | 0.55485433 |
| 107 | PRKG1 | 0.53737465 |
| 108 | MAP2K6 | 0.53527743 |
| 109 | BRSK2 | 0.53137548 |
| 110 | PRKD2 | 0.52818030 |
| 111 | PRKG2 | 0.52533517 |
| 112 | CAMK2G | 0.52273617 |
| 113 | CDK7 | 0.51141274 |
| 114 | PRKACG | 0.51082132 |
| 115 | SGK3 | 0.50803301 |
| 116 | NLK | 0.50672392 |
| 117 | TAOK2 | 0.49908768 |
| 118 | CSF1R | 0.48743984 |
| 119 | SGK2 | 0.48609666 |
| 120 | IGF1R | 0.48177234 |
| 121 | CDK4 | 0.47968982 |
| 122 | NEK2 | 0.46582349 |
| 123 | PRKCZ | 0.46197116 |
| 124 | MAP2K2 | 0.45999261 |
| 125 | STK38 | 0.45779633 |
| 126 | ABL1 | 0.44968591 |
| 127 | TTN | 0.43485979 |
| 128 | IRAK2 | 0.43410478 |
| 129 | CAMKK2 | 0.42178025 |
| 130 | IRAK4 | 0.41611581 |
| 131 | CAMK4 | 0.41483871 |
| 132 | EPHA4 | 0.41053277 |
| 133 | RPS6KA3 | 0.38989765 |
| 134 | EPHB1 | 0.38379625 |
| 135 | GRK7 | 0.38023685 |
| 136 | DAPK2 | 0.36009315 |
| 137 | PRKAA1 | 0.35850939 |
| 138 | SRC | 0.35462651 |
| 139 | RPS6KB1 | 0.35390804 |
| 140 | STK3 | 0.34388500 |
| 141 | MAP2K1 | 0.32172991 |
| 142 | MAP3K1 | 0.31962412 |
| 143 | MTOR | 0.31860394 |
| 144 | AKT2 | 0.31768709 |
| 145 | MAP3K5 | 0.31643098 |
| 146 | MAPK3 | 0.31154879 |
| 147 | CAMK1G | 0.29816584 |
| 148 | FER | 0.28944241 |
| 149 | PRKCH | 0.28836232 |
| 150 | PRKCQ | 0.27920169 |
| 151 | JAK3 | 0.25391958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30593902 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.23838590 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10584373 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84100572 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.79470571 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78733481 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70077284 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68723022 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55973220 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51668911 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44141750 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38693637 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28155602 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.23441303 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16698599 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07524449 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02979201 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02770047 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01008609 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99361321 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98416929 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97728405 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97539542 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89694660 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.86137761 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85079396 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83244767 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.82009345 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67855361 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.66759948 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57014215 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51874803 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50877092 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46950340 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44744558 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43712340 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.38724128 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36494170 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.30402033 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29331142 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29192923 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.25451784 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17831290 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16852153 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13929137 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13656778 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08962290 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07593267 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07049840 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06703234 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04247475 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03696897 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02008750 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00359574 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98555809 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.93489793 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93132984 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92567733 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90960675 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82702641 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75616150 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70992465 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67577652 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54897084 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49697224 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49643172 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49096897 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42909656 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40278065 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31477912 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27852015 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.26686934 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23968087 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.21912747 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19684640 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19129095 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.18858268 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17723796 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.12052562 |
| 80 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11413615 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09873604 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06706876 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05258574 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04676567 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.01696770 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.00858421 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00037123 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | -0.1585036 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1532164 |
| 90 | Pertussis_Homo sapiens_hsa05133 | -0.1403252 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1366714 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1342378 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | -0.1297089 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1254233 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1220336 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1100651 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1064559 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1061579 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1055510 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0977879 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0952886 |
| 102 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0894304 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0889325 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0826385 |
| 105 | * Lysosome_Homo sapiens_hsa04142 | -0.0773284 |
| 106 | Malaria_Homo sapiens_hsa05144 | -0.0649053 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0619496 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0610483 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0605966 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0257930 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0058104 |

